Cellosign

Company Overview

Snapshot

Founded in January 2014 by Kobi Segev and Osnat Attal-Damon, Cellosign operates with 11–50 employees. The company focuses on enhancing business processing for call centers through digital solutions. In October 2021, the company secured a new investment round to advance its technology platform.

Business overview

Cellosign develops an application designed to streamline business processing between customer service representatives and customers. Its core technology facilitates interactive document sharing, including real-time bi-directional viewing, annotation of data, and eSignatures. The company primarily serves call centers within the enterprise and professional services sectors, operating within the Business Software category, specifically focusing on Operations Solutions and Legal & Compliance Solutions.

Strategic signal

In October 2021, Cellosign secured a new investment round to further develop its proprietary iPSC-CAR-Macrophage technology platform. This signals a strategic commitment to advancing its core technological capabilities, which could lead to enhanced product offerings and market expansion within the digital signature and call center solutions space.

Company Intelligence Q&A

What is Cellosign's primary offering?

Cellosign provides an application that enables efficient business processing for call centers through interactive document sharing and eSignatures, aiming to increase transaction close rates and reduce complexity.

When was Cellosign founded?

Cellosign was founded in January 2014.

Who are the founders of Cellosign?

Cellosign was co-founded by Kobi Segev and Osnat Attal-Damon.

What significant funding event occurred for Cellosign in 2021?

In October 2021, Cellosign secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform.

In which markets does Cellosign primarily operate?

Cellosign operates in the United States, Israel, and the United Kingdom.